From study design and protocol development to site qualification, real-time quality review, advanced image analysis, and comprehensive reporting — delivered by a single integrated team.
We support and manage every stage of your imaging study, from early design through to secure data lock — with decades of multicentre imaging experience.
Our team has deep expertise in quantitative MRI techniques that generate reproducible, clinically meaningful biomarkers.
Dynamic contrast-enhanced MRI for perfusion and vascular permeability assessment.
Microstructural tissue characterisation including DTI, DKI, and IVIM modelling.
Oxygen-enhanced MRI for non-invasive assessment of tissue oxygenation and perfusion.
In vivo metabolite quantification for oncology, neuroimaging, and metabolic disease.
T1, T2, T2* and susceptibility mapping for tissue characterisation and iron quantification.
BOLD-based fMRI for neuroscience and CNS drug development biomarkers.
Ortex Solutions supports imaging across a broad range of biomarker development. MRI/PET/CT
Whether you're at the design stage or need support on an existing trial, our team is ready to help.
info@ortexsolutions.com